The Health Protection (Coronavirus Restrictions) (No. 5) (Wales) (Amendment) (No. 5) Regulations 2022

Amendment to the Health Protection (Coronavirus Restrictions) (No. 5) (Wales) Regulations 2020

2.—(1) The Health Protection (Coronavirus Restrictions) (No. 5) (Wales) Regulations 2020(1) are amended as follows.

(2) In regulation 3, for “25 February 2022” substitute “28 March 2022”.

(3) In regulation 10—

(a) for paragraph (5)(a) substitute—

“(a) has completed a course of doses of—

(i) an authorised vaccine, or

(ii) a vaccine under the United Kingdom vaccine roll-out overseas,

and the day on which the person had the close contact which resulted in the notification described in regulation 8(1) is more than 14 days after the day on which the person completed that course of doses, and”;

(b) for paragraph (7) substitute—

“(7) For the purposes of paragraph (5)—

(a) a person has completed a course of doses of an authorised vaccine—

(i) if the person has received the complete course of doses specified—

(aa) in the summary of product characteristics approved as part of the marketing authorisation for the authorised vaccine, or

(bb) in the instructions for usage approved as part of the authorisation by the licensing authority on a temporary basis under regulation 174 of the Human Medicines Regulations 2012(2);

(ii) if the person has received a dose of one authorised vaccine and a dose of a different authorised vaccine;

(iii) if the person has received at least two doses of any vaccine referred to in sub-paragraph (d) of the definition of “authorised vaccine” in regulation 3(14) of the International Travel Regulations;

(b) a person has completed a course of doses of a vaccine under the United Kingdom vaccine roll-out overseas—

(i) if the person has received the complete course of doses of a vaccine as specified in the manufacturer’s guidance for that vaccine;

(ii) if the person has received a dose of one vaccine under the United Kingdom vaccine roll-out overseas and a dose of a different vaccine under the United Kingdom vaccine roll-out overseas;

(iii) if the person has received a dose of an authorised vaccine and a dose of a vaccine under the United Kingdom vaccine roll-out overseas.”

(c) in paragraph (8)—

(i) for sub-paragraph (a) substitute—

“(a) “authorised vaccine” has the meaning given in regulation 3(14) of the International Travel Regulations;”;

(ii) after sub-paragraph (b) insert—

“(ba) “the International Travel Regulations” means the Health Protection (Coronavirus, International Travel) (Wales) Regulations 2022(3);”;

(iii) in sub-paragraph (d), for “regulation 8(1) of the Human Medicines Regulations 2012” substitute “regulation 3(14) of the International Travel Regulations”;

(iv) after sub-paragraph (e) insert—

“(f) “United Kingdom vaccine roll-out overseas” has the meaning given in regulation 3(14) of the International Travel Regulations.”

(4) Omit regulation 10C.

(5) Before regulation 11 insert—

“Transitional provision: isolation requirements

10D.   Where—

(a) a person (“P”) is required to not leave or be outside of the place where P is living in accordance with regulation 8(2) (“P’s isolation requirement”) immediately before 18 February 2022, and

(b) had P been given a notification described in regulation 8(1) on or after that date, P would (because of the application of regulation 10(5) as amended by the Health Protection (Coronavirus Restrictions) (No. 5) (Wales) (Amendment) (No. 5) Regulations 2022) be excepted from the requirement to not leave or be outside of the place where P is living in accordance with regulation 8(2),

P’s isolation requirement ceases to apply at the beginning of 18 February 2022.”

(6) Omit regulation 16A.

(7) In regulation 18(1), omit “or 16A(1)”.

(8) In regulation 25(3)(a)(i), omit “or 16A(1)”.

(9) In regulation 26, for “regulations 16(1) and 16A(1)” substitute “regulation 16”.

(10) Omit regulation 30A.

(11) Omit regulation 40A.

(12) In Schedule 8—

(a) in paragraph 1—

(i) in sub-paragraph (1)(a), omit “or 16A”;

(ii) in sub-paragraph (2)(b), omit “or 16A”;

(b) in paragraph 2—

(i) in sub-paragraph (3)(a), omit “or 16A”;

(ii) in sub-paragraph (4)(b)(ii), omit “or 16A”;

(iii) in sub-paragraph (4)(c), omit “or 16A”;

(c) in paragraph 3(3)(c), omit “or 16A”;

(d) in paragraph 4(1)(b), omit “or 16A”.

(1)

S.I. 2020/1609 (W. 335) as amended by S.I. 2020/1610 (W. 336), S.I. 2020/1623 (W. 340), S.I. 2020/1645 (W. 345), S.I. 2021/20 (W. 7), S.I. 2021/46 (W. 10), S.I. 2021/57 (W. 13), S.I. 2021/66 (W. 15), S.I. 2021/95 (W. 26), S.I. 2021/103 (W. 28), S.I. 2021/172 (W. 40), S.I. 2021/210 (W. 52), S.I. 2021/307 (W. 79), S.I. 2021/413 (W. 133), S.I. 2021/502 (W. 150), S.I. 2021/542 (W. 154), S.I. 2021/583 (W. 160), S.I. 2021/668 (W. 169), S.I. 2021/686 (W. 172), S.I. 2021/722 (W. 183), S.I. 2021/862 (W. 201), S.I. 2021/925 (W. 210), S.I. 2021/970 (W. 228), S.I. 2021/1119 (W. 271), S.I. 2021/1131 (W. 274), S.I. 2021/1212 (W. 303), S.I. 2021/1304 (W. 334), S.I. 2021/1363 (W. 358), S.I. 2021/1407 (W. 366), S.I. 2021/1468 (W. 376), S.I. 2021/1477 (W. 379), S.I. 2021/1485 (W. 386), S.I. 2021/1490 (W. 390), S.I. 2022/39 (W. 16), S.I. 2022/55 (W. 21), S.I. 2022/75 (W. 27) and S.I. 2022/83 (W. 29).

(2)

S.I. 2012/1916.

(3)

S.I. 2022/126 (W. 41).